Dr. Lal Pathlabs
BSE: 539524 | NSE: LALPATHLAB | ISIN: INE600L01024 | SECTOR: Healthcare FacilitiesOpen
2,643.10High
2,679.35Low
2,643.10Prev Close
2,646.35P/E
-Median P/E
-P/B
-Median P/B
-Market Cap
221.88BVolume
1.47KVol. (20 day Avg.)
0PEG
-Div.Yield
-Bid
-Ask
-
Company Description
- Healthcare Facilities
BSE
539524NSE
LALPATHLABISIN
INE600L01024
Dr. Lal PathLabs Limited is an India-based company that is engaged in providing diagnostic and related healthcare tests and services. The Company is engaged in the business of running laboratories for carrying out pathological investigations of various branches of biochemistry, hematology, histopathology, microbiology, electrophoresis, immuno-chemistry, immunology, virology, cytology, and other pathological and radiological investigations. It offers a range of tests by condition, which includes allergy, diabetes, health checkups, viral infections, fever, heart diseases, hypertension, cancer, abortions, anemia, arthritis, breast cancer, diphtheria, disorder of the liver, disorders of bone, drugs of abuse, infertility, lymphoma, tuberculosis, ovarian cancer, osteoporosis, multiple sclerosis, muscular disorder, and viral infections. The Company’s subsidiaries include Paliwal Diagnostics Private Limited, Paliwal Medicare Private Limited, and Dr. Lal PathLabs Nepal Private Limited.
Company Officers
Arvind Lal
Executive Chairman of the BoardBharath Uppiliappan
Chief Executive OfficerVed Goel
Chief Financial OfficerShankha Banerjee
Chief Executive Officer Group - Associates CompaniesJai Meena
Chief Operating OfficerManoj Garg
Chief Human Resource OfficerMunender Soperna
Chief Information OfficerVinay Gujral
Compliance Officer, Company SecretaryOm Manchanda
Managing Director, Executive DirectorVandana Lal
Executive Director